All content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.

Peptide register

Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.

Sort

Class

Legal status

9 of 98

Ac-SDKP (goralatide) AC-SDKP

Tissue repairResearch chemical

Endogenous tetrapeptide from thymosin beta-4, a marker of ACE inhibition; tested as goralatide in the 1990s, never approved.

Early clinical development in the 1990s, not continued; not approved in any market

Monograph

Ara-290 (cibinetide) ARA-290

Tissue repairIn clinical development

Erythropoietin-derived innate repair receptor agonist studied in phase 2; not approved anywhere.

Monograph

BPC-157

Tissue repairResearch chemical

Synthetic pentadecapeptide studied mainly in animal models; no approval anywhere.

Australia: Schedule 4

Monograph

KPV

Tissue repairResearch chemical

Tripeptide fragment of alpha-melanocyte-stimulating hormone; preclinical only, no approval.

Monograph

LL-37

Tissue repairIn clinical development

Human cathelicidin antimicrobial peptide studied in phase 2 wound trials; not approved anywhere.

Monograph

PTD-DBM PTD

Tissue repairResearch chemical

Cell-penetrating peptide blocking the CXXC5-Dishevelled interaction; preclinical only, not approved anywhere.

Monograph

TB-4 (Thymosin β4) TB-4

Tissue repairIn clinical development

Full-length thymosin beta-4: 43 amino acids; studied in clinical trials, distinct from the TB-500 fragment.

Monograph

TB-500

Tissue repairResearch chemical

Acetylated seven-amino-acid fragment of thymosin beta-4 (Ac-LKKTETQ); distinct from full-length TB-4.

Monograph

TB-500 Fragment (17-23) TB-FRAG

Tissue repairResearch chemical

Non-acetylated thymosin beta-4 fragment (17-23), INN fequesetide; TB-500 is the acetylated form. Approved nowhere.

Monograph

Take myPeptides with you

Track doses, plans and progress on your phone — end-to-end encrypted.

This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.